Young: So you cant just create a full copycat medication of these drugs
FDA has given these companies a facility-dependent grace period of 60 to 90 days to stop selling compounded GLP-1 drugs before the agency takes enforcement action, aiming to avoid unnecessary disruptions in patient care
Tirzepatide, a dual GIP/GLP-1 agonist, has demonstrated superior weight loss efficacy, reshaping prescriber preferences in obesity management
Zepbound is part of a medication class called dual glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 (GLP-1) receptor agonists
Among the tissues and organs crucial in regulating glucose and lipid metabolism, pancreas, brain, and adipocytes express GIP receptors (GIPRs), while pancreas, brain, and gastrointestinal tract are rich in GLP-1 receptors (GLP-1Rs) ( The hormonal binding at the extracellular domain is communicated to the intracellular receptor side, leading to G protein engagement and activation ( 2.3 Interaction of GIP and GLP-1 in the incretin effect Studies in rodents ( Figure 1 Section A]
